Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × FED × ADI PEG20 × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 9 OTHER 3 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Melanoma 1

Interventions

sargramostim 1 pembrolizumab 1 Injections 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Exercise 1 Cryotherapy 1 Cryosurgery 1 Clofarabine 1 Celecoxib 1 Capecitabine 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡